company
MICRO LABS
Jurisdiction: US
FDA Warning Letter timeline
V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.
- fda_approval · anda2026-06-30MICRO LABS — ANDA approval: RIVAROXABAN (unspecified)
- fda_approval · anda2026-06-29MICRO LABS — ANDA approval: PRUCALOPRIDE SUCCINATE (unspecified)
- fda_approval · anda2026-06-24MICRO LABS — ANDA approval: PROPRANOLOL HYDROCHLORIDE (unspecified)
- fda_approval · anda2026-06-23MICRO LABS — ANDA approval: FLUVOXAMINE MALEATE (unspecified)
Frequently asked questions
- How many FDA warning letters has MICRO LABS received?
- Argus HQ has not recorded an FDA warning letter for MICRO LABS in our current dataset.
- What FDA recalls has MICRO LABS issued?
- Argus HQ has not recorded an FDA recall tied to MICRO LABS in our current dataset.
- Is MICRO LABS FDA compliant?
- Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 0 recalls, and 4 approval records for MICRO LABS. Review the linked FDA source records directly before drawing a compliance conclusion.
Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.